Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Harle

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Journal of Pain and Symptom Management|September 1, 1996
Response to intravenous lidocaine infusion predicts subsequent response to oral mexiletine: a prospective studyB S Galer, J Harle, M C Rowbotham
Phlebologie|April 1, 1981
[Value of rheoplethysmography with venous occlusion in the detection of venous thrombosis]P Langeron, F Wuydin, L Croccel, et al.
Journal of Materials Science. Materials in Medicine|September 7, 2004
Effects of therapeutic ultrasound on osteoblast gene expressionJ Harle, V Salih, J C Knowles, et al.
Ultrasound in Medicine & Biology|May 23, 2001
Effects of ultrasound on the growth and function of bone and periodontal ligament cells in vitroJ Harle, V Salih, F Mayia, et al.
Journal of Materials Science. Materials in Medicine|May 11, 2005
Gene expression profiling of bone cells on smooth and rough titanium surfacesJ Harle, V Salih, I Olsen, et al.
Oncotarget|September 13, 2014
Deubiquitinating enzyme Usp12 regulates the interaction between the androgen receptor and the Akt pathwayUrszula L McClurg, Emma E Summerscales, Victoria J Harle, et al.
Bone|June 23, 2004
Roughness response genes in osteoblastsP M Brett, J Harle, V Salih, et al.
Neurology|November 4, 2000
Lack of efficacy of riluzole in the treatment of peripheral neuropathic pain conditionsB S Galer, L L Twilling, J Harle, et al.
The Journal of Biological Chemistry|September 24, 2013
Deubiquitinating enzyme Usp12 is a novel co-activator of the androgen receptorUrszula L Burska, Victoria J Harle, Kelly Coffey, et al.
Oncotarget|October 14, 2015
Ubiquitin-specific protease 12 interacting partners Uaf-1 and WDR20 are potential therapeutic targets in prostate cancerUrszula L McClurg, Victoria J Harle, Arash Nabbi, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Pain and Symptom Management|September 1, 1996
Response to intravenous lidocaine infusion predicts subsequent response to oral mexiletine: a prospective studyB S Galer, J Harle, M C Rowbotham
Phlebologie|April 1, 1981
[Value of rheoplethysmography with venous occlusion in the detection of venous thrombosis]P Langeron, F Wuydin, L Croccel, et al.
Journal of Materials Science. Materials in Medicine|September 7, 2004
Effects of therapeutic ultrasound on osteoblast gene expressionJ Harle, V Salih, J C Knowles, et al.
Ultrasound in Medicine & Biology|May 23, 2001
Effects of ultrasound on the growth and function of bone and periodontal ligament cells in vitroJ Harle, V Salih, F Mayia, et al.
Journal of Materials Science. Materials in Medicine|May 11, 2005
Gene expression profiling of bone cells on smooth and rough titanium surfacesJ Harle, V Salih, I Olsen, et al.
Oncotarget|September 13, 2014
Deubiquitinating enzyme Usp12 regulates the interaction between the androgen receptor and the Akt pathwayUrszula L McClurg, Emma E Summerscales, Victoria J Harle, et al.
Bone|June 23, 2004
Roughness response genes in osteoblastsP M Brett, J Harle, V Salih, et al.
Neurology|November 4, 2000
Lack of efficacy of riluzole in the treatment of peripheral neuropathic pain conditionsB S Galer, L L Twilling, J Harle, et al.
The Journal of Biological Chemistry|September 24, 2013
Deubiquitinating enzyme Usp12 is a novel co-activator of the androgen receptorUrszula L Burska, Victoria J Harle, Kelly Coffey, et al.
Oncotarget|October 14, 2015
Ubiquitin-specific protease 12 interacting partners Uaf-1 and WDR20 are potential therapeutic targets in prostate cancerUrszula L McClurg, Victoria J Harle, Arash Nabbi, et al.
Pageof 2